Setsuko Kunimoto

1.7k total citations
46 papers, 1.4k citations indexed

About

Setsuko Kunimoto is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Setsuko Kunimoto has authored 46 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 13 papers in Pharmacology and 10 papers in Organic Chemistry. Recurrent topics in Setsuko Kunimoto's work include Microbial Natural Products and Biosynthesis (11 papers), Cancer therapeutics and mechanisms (8 papers) and Cancer, Hypoxia, and Metabolism (8 papers). Setsuko Kunimoto is often cited by papers focused on Microbial Natural Products and Biosynthesis (11 papers), Cancer therapeutics and mechanisms (8 papers) and Cancer, Hypoxia, and Metabolism (8 papers). Setsuko Kunimoto collaborates with scholars based in Japan and United Kingdom. Setsuko Kunimoto's co-authors include TOMIO TAKEUCHI, HAMAO UMEZAWA, TAKAAKI AOYAGI, Yohko Yamazaki, MASA HAMADA, Daishiro Ikeda, HIROSHI NAGANAWA, HIRONOBU IINUMA, Hiroyasu Esumi and Shinichi Kondo and has published in prestigious journals such as Biochemical and Biophysical Research Communications, FEBS Letters and Journal of Bacteriology.

In The Last Decade

Setsuko Kunimoto

46 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Setsuko Kunimoto Japan 19 871 299 282 223 200 46 1.4k
Daishiro Ikeda Japan 27 1.1k 1.3× 679 2.3× 660 2.3× 265 1.2× 273 1.4× 120 2.0k
Russell B. Lingham United States 27 824 0.9× 460 1.5× 576 2.0× 201 0.9× 219 1.1× 50 1.7k
Richard F. Camalier United States 14 884 1.0× 253 0.8× 149 0.5× 92 0.4× 229 1.1× 21 1.5k
YASUHISA TSURUMI Japan 19 811 0.9× 388 1.3× 569 2.0× 224 1.0× 90 0.5× 58 1.5k
Michael C. Bibby United Kingdom 20 778 0.9× 291 1.0× 111 0.4× 93 0.4× 389 1.9× 47 1.7k
Charles A. Omer United States 29 1.5k 1.7× 295 1.0× 191 0.7× 78 0.3× 499 2.5× 52 2.1k
Hidesuke Fukazawa Japan 23 882 1.0× 163 0.5× 161 0.6× 116 0.5× 329 1.6× 50 1.6k
TSUTOMU SAWA Japan 26 1.2k 1.4× 888 3.0× 906 3.2× 307 1.4× 345 1.7× 110 2.3k
Dale T. Blankenship United States 21 997 1.1× 79 0.3× 201 0.7× 109 0.5× 74 0.4× 26 1.8k
Nathaniel H. Greenberg United States 6 536 0.6× 191 0.6× 120 0.4× 92 0.4× 261 1.3× 9 1.1k

Countries citing papers authored by Setsuko Kunimoto

Since Specialization
Citations

This map shows the geographic impact of Setsuko Kunimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Setsuko Kunimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Setsuko Kunimoto more than expected).

Fields of papers citing papers by Setsuko Kunimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Setsuko Kunimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Setsuko Kunimoto. The network helps show where Setsuko Kunimoto may publish in the future.

Co-authorship network of co-authors of Setsuko Kunimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Setsuko Kunimoto. A scholar is included among the top collaborators of Setsuko Kunimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Setsuko Kunimoto. Setsuko Kunimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Momose, Isao, et al.. (2009). Inhibitors of insulin-like growth factor-1 receptor tyrosine kinase are preferentially cytotoxic to nutrient-deprived pancreatic cancer cells. Biochemical and Biophysical Research Communications. 380(1). 171–176. 11 indexed citations
2.
Masuda, Toru, Shun‐ichi Ohba, Manabu Kawada, et al.. (2006). Antitumor Effect of Kigamicin D on Mouse Tumor Models. The Journal of Antibiotics. 59(4). 209–214. 19 indexed citations
3.
Someno, Tetsuya, Setsuko Kunimoto, H. Nakamura, HIROSHI NAGANAWA, & Daishiro Ikeda. (2005). Absolute Configuration of Kigamicins A, C and D. The Journal of Antibiotics. 58(1). 56–60. 29 indexed citations
4.
Lu, Jie, Setsuko Kunimoto, Yohko Yamazaki, Michio Kaminishi, & Hiroyasu Esumi. (2004). Kigamicin D, a novel anticancer agent based on a new anti‐austerity strategy targeting cancer cells' tolerance to nutrient starvation. Cancer Science. 95(6). 547–552. 95 indexed citations
5.
Kunimoto, Setsuko, Tetsuya Someno, Yohko Yamazaki, et al.. (2003). Kigamicins, Novel Antitumor Antibiotics: II. Structure Determination. The Journal of Antibiotics. 56(12). 1012–1017. 45 indexed citations
6.
Kunimoto, Setsuko, Jie Lü, Hiroyasu Esumi, et al.. (2003). Kigamicins, Novel Antitumor Antibiotics: I. Taxonomy, Isolation, Physico-chemical Properties and Biological Activities. The Journal of Antibiotics. 56(12). 1004–1011. 48 indexed citations
7.
Kunimoto, Setsuko, et al.. (1999). Stimulation of Cellular XTT Reduction by Cytochrome Oxidase Inhibitors.. Biological and Pharmaceutical Bulletin. 22(6). 660–661. 8 indexed citations
8.
Kunimoto, Setsuko, et al.. (1999). Inhibition of Nitric Oxide Synthase Induction by 15-Deoxyspergualin in a Cultured Macrophage Cell Line, J744A.1 Activated with IFN-.GAMMA. and LPS.. The Journal of Antibiotics. 52(3). 297–304. 5 indexed citations
9.
Momose, Isao, HIRONOBU IINUMA, Naoko Kinoshita, et al.. (1999). Decatromicins A and B, New Antibiotics Produced by Actinomadura sp. MK73-NF4. I. Taxonomy, Isolation, Physico-chemical Properties and Biological Activities.. The Journal of Antibiotics. 52(9). 781–786. 18 indexed citations
10.
Ishii, Tomonori, et al.. (1997). Inhibition of Anchorage-Independent Growth of Tumor Cells by IT-62-B, a New Anthracycline.. The Journal of Antibiotics. 50(10). 853–859. 1 indexed citations
11.
Yoshida, Kiyotsugu, et al.. (1995). Eulicin Inhibits Human Immunodeficiency Virus Infection and Replication.. The Journal of Antibiotics. 48(11). 1362–1363. 2 indexed citations
12.
Kunimoto, Setsuko & TOMIO TAKEUCHI. (1994). Kinetic studies of the interaction between spergualin or 15-deoxyspergualin and amine oxidase from bovine plasma.. The Journal of Antibiotics. 47(10). 1130–1135. 1 indexed citations
13.
Kunimoto, Setsuko, et al.. (1990). Biological activities of new anthracyclines containing fluorine, FAD 104 and its metabolites.. The Journal of Antibiotics. 43(5). 556–565. 3 indexed citations
14.
Kunimoto, Setsuko. (1989). Basic studies on spergualins.. 179–191. 1 indexed citations
15.
Kunimoto, Setsuko, et al.. (1989). Serum effect on cellular uptake of spermidine, spergualin, 15-deoxyspergualin, and their metabolites by L5178Y cells.. The Journal of Antibiotics. 42(1). 116–122. 8 indexed citations
16.
Imoto, Masaya, Kazuo Umezawa, KUNIO ISSHIKI, et al.. (1987). Kinetic studies of tyrosine kinase inhibition by erbstatin.. The Journal of Antibiotics. 40(10). 1471–1473. 47 indexed citations
17.
UMEZAWA, HAMAO, Shinichi Kondo, HIRONOBU IINUMA, et al.. (1981). Structure of an antitumor antibiotic, spergualin.. The Journal of Antibiotics. 34(12). 1622–1624. 93 indexed citations
18.
Kunimoto, Setsuko, et al.. (1974). MECHANISM OF INHIBITION OF PEPSIN BY PEPSTATIN. II. The Journal of Antibiotics. 27(6). 413–418. 30 indexed citations
19.
Kunimoto, Setsuko, et al.. (1973). [Inhibitory activity of pepstatin against acid protease and a method of estimating acid protease in gastric juice].. PubMed. 26(2). 109–14. 1 indexed citations
20.
AOYAGI, TAKAAKI, Hajime Morishima, RINZO NISHIZAWA, et al.. (1972). BIOLOGICAL ACTIVITY OF PEPSTATINS, PEPSTANONE A AND PARTIAL PEPTIDES ON PEPSIN, CATHEPSIN D AND RENIN. The Journal of Antibiotics. 25(12). 689–694. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026